Endothelium-derived hyperpolarizing factor and pregnancy: Possible contribution in regulation of vascular signaling mechanisms in normotensive and hypertensive setting

Pregnancy: Risk Factors, Management and Recovery

Volumn , Issue , 2012, Pages 205-220

  Radenković, Miroslav ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874590580     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (48)

1. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension, 2001;38:718-22.
2. Ang C, Lumsden MA. Diabetes and the maternal resistance vasculature. Clin. Sci., (Lond). 2001 Dec; 101(6):719-29.
3. Dørup I, Skajaa K, Sørensen KE. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am. J. Physiol., 1999; 276: H821-5.
4. Radenkovic M, Grbovic L, Radunovic N, Momcilov P. Pharmacological evaluation of bradykinin effect on human umbilical artery in normal, hypertensive and diabetic pregnancy. Pharmacol. Rep., 2007; 59:64-73.
5. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta, 2002 May; 23(5):359-72.
6. Kanayama N. Trophoblastic injury: new etiological and pathological concept of preeclampsia. Croat. Med. J., 2003 Apr; 44(2):148-56.
7. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2002; 283: R29-45.
8. Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J. Clin. Pathol., 2008; 61:1254-60.
9. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol., 2006; 27:399-404.
10. Baumwell S, Karumanchi SA. Pre-Eclampsia: Clinical Manifestations and Molecular Mechanisms. Nephron. Clin. Pract., 2007; 106: c72-81.
11. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet, 2005; 365:785-99.
12. Sandow SL. Factors, fiction and endothelium-derived hyperpolarizing factor. Clin. Exp. Pharmacol. Physiol., 2004; 31:563-70.
13. Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol. Res., 2004; 49:525-33.
14. Edwards G, Weston AH. Potassium and potassium clouds in endothelium-dependent hyperpolarizations. Pharmacol. Res., 2004; 49:535-41.
15. Griffith TM. Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br. J. Pharmacol., 2004; 141:881-903.
16. Rummery NM, Hill CE. Vascular gap junctions and implications for hypertension. Clin. Exp. Pharmacol. Physiol., 2004; 31:659-67.
17. Lang NN, Luksha L, Newby DE, Kublickiene K. Connexin 43 mediates endotheliumderived hyperpolarizing factor-induced vasodilatation in subcutaneous resistance arteries from healthy pregnant women. Am. J. Physiol. Heart Circ. Physiol., 2007; 292: H1026-32.
18. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation, 2005; 12:113-27.
19. Chauhan SD, Hobbs AJ, Ahluwalia A. C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factor. Int. J. Biochem. Cell Biol., 2004; 36:1878-81.
20. Ahluwalia A, Hobbs AJ. Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor. Trends Pharmacol. Sci., 2005; 26:162-7.
21. Ellis A, Triggle CR. Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone. Can. J. Physiol. Pharmacol., 2003; 81:1013-28.
22. Shimokawa H, Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol. Res., 2004; 49:543-9.
23. Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, Kendall DA. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun., 1996; 229:114-20.
24. Randall MD, McCulloch AI, Kendall DA. Comparative pharmacology of endotheliumderived hyperpolarizing factor and anandamide in rat isolated mesentery. Eur. J. Pharmacol., 1997; 333:191-7.
25. Randall MD, Kendall DA. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur. J. Pharmacol., 1997; 335:205-9.
26. Bobadilla RA, Henkel CC, Henkel EC, Escalante B, Hong E. Possible involvement of endothelium-derived hyperpolarizing factor in vascular responses of abdominal aorta from pregnant rats. Hypertension, 1997; 30:596-602.
27. Hagedorn KA, Cooke CL, Falck JR, Mitchell BF, Davidge ST. Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor. Hypertension, 2007; 49:328-33.
28. Gerber RT, Anwar MA, Poston L. Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium-derived hyperpolarizing factor (EDHF). Br. J. Pharmacol., 1998; 125:455-60.
29. Resende AC, Pimentel AM, de Moura RS. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats. Clin. Exp. Pharmacol. Physiol., 2004; 31:756-61.
30. Keyes L, Rodman DM, Curran-Everett D, Morris K, Moore LG. Effect of K+ATP channel inhibition on total and regional vascular resistance in guinea pig pregnancy. Am. J. Physiol., 1998; 275: H680-8.
31. Meziani F, Van Overloop B, Schneider F, Gairard A. Parathyroid hormone-related protein-induced relaxation of rat uterine arteries: influence of the endothelium during gestation. J. Soc. Gynecol. Investig., 2005; 12:14-9.
32. Gillham JC, Myers JE, Baker PN, Taggart MJ. Regulation of endothelial-dependent relaxation in human systemic arteries by SKCa and IKCa channels. Reprod. Sci., 2007; 14:43-50.
33. Dalle Lucca JJ, Adeagbo AS, Alsip NL. Influence of oestrous cycle and pregnancy on the reactivity of the rat mesenteric vascular bed. Hum. Reprod., 2000; 15:961-8.
34. Dalle Lucca JJ, Adeagbo AS, Alsip NL. Oestrous cycle and pregnancy alter the reactivity of the rat uterine vasculature. Hum. Reprod., 2000a; 15:2496-503.
35. Fulep EE, Vedernikov YP, Saade GR, Garfield RE. The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats. Am. J. Obstet. Gynecol., 2001; 185:638-42.
36. Gokina NI, Kuzina OY, Vance AM. Augmented EDHF signaling in rat uteroplacental vasculature during late pregnancy. Am. J. Physiol. Heart Circ. Physiol., 2010; 299: H1642-52.
37. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin. Sci., (Lond). 2002; 103:67-73.
38. Mateev S, Sillau AH, Mouser R, McCullough RE, White MM, Young DA, Moore LG. Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow. Am. J. Physiol. Heart Circ. Physiol., 2003; 284: H820-9.
39. CipollaMJ, Vitullo L, McKinnon J. Cerebral artery reactivity changes during pregnancy and the postpartum period: a role in eclampsia? Am. J. Physiol. Heart Circ. Physiol., 2004; 286: H2127-32.
40. Chaytor AT, Evans WH, Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J. Physiol., 1998; 508:561-73.
41. Taylor HJ, Chaytor AT, Evans WH, Griffith TM. Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-alpha glycyrrhetinic acid. Br. J. Pharmacol., 1998; 125:1-3.
42. Harris D, Martin PE, Evans WH, Kendall DA, Griffith TM, Randall MD. Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K(+)-relaxation. Eur. J. Pharmacol., 2000; 402:119-28.
43. Coleman HA, Tare M, Parkington HC. K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels. J. Physiol., 2001; 531:359-73.
44. Gillham JC, Kenny LC, Baker PN. An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol., 2003; 109:2-7.
45. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women. Br. J. Pharmacol., 2002a; 136:1085-8.
46. Luksha L, Nisell H, Kublickiene K. The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2004; 286: R1102-9.
47. Luksha L, Nisell H, Luksha N, Kublickas M, Hultenby K, Kublickiene K. Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008; 294: R510-9.
48. Luksha L, Luksha N, Kublickas M, Nisell H, Kublickiene K. Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia. Biol. Reprod., 2010; 83:728-35.